Percutaneous treatment of de Quervain’s disease using Sono-Instruments®: A feasibility study

Abstract

We investigated the safety and effectiveness of percutaneous release for de Quervain’s disease using Sono-Instruments® in cadaveric specimens. The mean procedure duration was 4 minutes, and complete release was achieved in all specimens.

Keywords

Anatomical visualization cadaveric study de Quervain’s tenosynovitis first extensor compartment percutaneous treatment Sono-Instrument®ultrasonography retinaculum release

Get full access to this article

View all access options for this article.

References

Bosman

Duraku

Van Der Oest

MJW

, et al. Surgical treatment outcome of de Quervain’s disease: A systematic review and meta-analysis. Plast Reconstr Surg Glob Open. 2022, 10: e4305.

Choi

Ahn

Lee

, et al. De Quervain disease: US identification of anatomic variations in the first extensor compartment with an emphasis on subcompartmentalization. Radiology. 2011, 260: 480–6.

Moungondo

Van Rompaey

Moussa

Schuind

Prospective evaluation of a novel device for ultrasound-guided percutaneous treatment of carpal tunnel and trigger finger disease. Efficacy and safety of Sono-Instruments®. J Ultrasound. 2024, 27: 873–85.